Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Pollen Allergenic Extract [EPC]
Xanthium Strumarium Var. Canadense Pollen is a non-standardized allergenic extract used for the diagnosis and treatment of Cocklebur-related allergies through skin testing and immunotherapy.
Name
Xanthium Strumarium Var. Canadense Pollen
Raw Name
XANTHIUM STRUMARIUM VAR. CANADENSE POLLEN
Category
Non-Standardized Pollen Allergenic Extract [EPC]
Drug Count
6
Variant Count
6
Last Verified
February 17, 2026
About Xanthium Strumarium Var. Canadense Pollen
Xanthium Strumarium Var. Canadense Pollen is a non-standardized allergenic extract used for the diagnosis and treatment of Cocklebur-related allergies through skin testing and immunotherapy.
Detailed information about Xanthium Strumarium Var. Canadense Pollen
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Xanthium Strumarium Var. Canadense Pollen.
Xanthium Strumarium Var. Canadense Pollen, commonly known as Cocklebur pollen, is a biological substance classified as a Non-Standardized Pollen Allergenic Extract [EPC]. This extract is derived from the pollen of the Xanthium strumarium plant, a member of the Asteraceae (Compositae) family. In clinical practice, this agent is utilized by allergists and immunologists primarily for two purposes: the diagnostic identification of specific allergic sensitivities via skin testing and the therapeutic desensitization of patients through subcutaneous immunotherapy (SCIT), often referred to as "allergy shots."
As a non-standardized extract, the potency of Xanthium Strumarium Var. Canadense Pollen is typically expressed in terms of weight/volume (w/v) or Protein Nitrogen Units (PNU), rather than standardized bioequivalent units. This distinguishes it from extracts like Grass or Dust Mite, which have federally mandated potency standards. The FDA has historically regulated these biological products under the Public Health Service Act, ensuring that they are manufactured under stringent conditions to maintain consistency in their complex protein profiles.
The mechanism of action for Xanthium Strumarium Var. Canadense Pollen varies depending on whether it is used for diagnosis or therapy. At the molecular level, the extract contains a variety of proteins and glycoproteins that act as antigens.
When used in skin testing (prick or intradermal), the pollen proteins are introduced into the skin. In individuals who are sensitized, these proteins cross-link specific Immunoglobulin E (IgE) antibodies bound to the surface of mast cells and basophils. This cross-linking triggers degranulation, releasing inflammatory mediators such as histamine, leukotrienes, and prostaglandins. This results in a localized "wheal and flare" reaction (a raised bump and surrounding redness), which confirms the patient's sensitivity to Cocklebur pollen.
The therapeutic use of the extract involves the repeated subcutaneous administration of gradually increasing doses of the allergen. This process, known as Hyposensitization or Immunotherapy, aims to shift the immune system's response from a Th2-dominated (allergic) profile to a Th1-dominated or T-regulatory (Treg) profile. Key molecular changes include:
Traditional pharmacokinetic parameters (Absorption, Distribution, Metabolism, Elimination) are not typically applied to allergenic extracts in the same way they are to synthetic small-molecule drugs, as these are biological proteins intended for local immune interaction rather than systemic pharmacological activity.
Xanthium Strumarium Var. Canadense Pollen is FDA-approved for the following indications:
This extract is available in several liquid concentrations, usually provided in multi-dose vials:
> Important: Only your healthcare provider can determine if Xanthium Strumarium Var. Canadense Pollen is right for your specific condition. The administration must be performed by a trained professional equipped to handle emergency allergic reactions.
Dosage for Xanthium Strumarium Var. Canadense Pollen is highly individualized and must be determined by an allergist based on the patient's sensitivity level and clinical history. There is no "standard" dose.
Immunotherapy is divided into two phases:
While Xanthium Strumarium Var. Canadense Pollen is used in children, the dosage must be adjusted with extreme caution. Children under the age of 5 may have difficulty cooperating with the 30-minute post-injection observation period and may be at a higher risk for systemic reactions. Pediatric dosing follows the same build-up logic as adult dosing but may start at even lower concentrations if the child is highly sensitive.
No specific dosage adjustments are required for patients with renal impairment, as the extract is not primarily cleared by the kidneys in a manner that affects its safety profile.
No dosage adjustments are necessary for patients with hepatic impairment.
Caution is advised in elderly patients, particularly those with underlying cardiovascular disease. The risk of using epinephrine to treat a systemic reaction must be weighed against the benefits of immunotherapy in this population.
This medication is NEVER self-administered. It must be administered by a healthcare professional in a clinical setting equipped with oxygen, epinephrine, and airway management tools.
If a dose is missed during the build-up phase, the next dose may need to be reduced or the previous dose repeated to maintain safety. If a maintenance dose is missed for more than 4-6 weeks, the allergist will typically reduce the dose and gradually build back up to the maintenance level. Consult your physician immediately if you miss a scheduled injection.
An "overdose" in the context of allergenic extracts refers to the administration of a dose that exceeds the patient's current tolerance level. Signs include:
In the event of an accidental overdose or severe reaction, epinephrine (1:1000) is the first-line treatment, followed by antihistamines and corticosteroids. Emergency medical services should be contacted immediately if symptoms occur outside the clinic.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance.
Most patients undergoing immunotherapy with Xanthium Strumarium Var. Canadense Pollen will experience some form of local reaction. These are generally not dangerous but can be uncomfortable.
> Warning: Stop taking Xanthium Strumarium Var. Canadense Pollen and call your doctor immediately if you experience any of these.
There are no known long-term adverse effects associated with the proper use of allergenic extracts like Xanthium Strumarium Var. Canadense Pollen. Immunotherapy has been used for over a century, and studies show that it does not increase the risk of autoimmune diseases or cancer. In fact, long-term use is associated with a decreased risk of developing new sensitivities (ne sensitization) and a lower likelihood of progression from allergic rhinitis to asthma.
While non-standardized extracts may not always carry a formal "Black Box Warning" in the same format as tablets, the FDA-approved labeling for all allergenic extracts contains a boxed warning regarding the risk of severe systemic reactions.
Summary of Warning: Xanthium Strumarium Var. Canadense Pollen can cause severe, life-threatening systemic reactions, including anaphylaxis. It must only be administered by physicians who are experienced in the treatment of anaphylaxis and the use of emergency equipment. Patients with unstable asthma are at a higher risk for fatal reactions. Patients must be observed for at least 30 minutes following administration.
Report any unusual symptoms to your healthcare provider.
Xanthium Strumarium Var. Canadense Pollen is intended for use only by clinicians specialized in allergy and immunology. The most critical safety consideration is the potential for a systemic allergic reaction. Patients must be in a stable state of health before receiving an injection; for example, if a patient is currently experiencing an asthma flare or a severe respiratory infection, the injection should be postponed.
No specific FDA black box warning exists for this specific varietal, but all allergenic extracts carry a general boxed warning for Anaphylaxis Risk. The warning emphasizes that these products can cause life-threatening reactions and must be administered in a setting where emergency resuscitation is possible. It also notes that certain medications, like beta-blockers, can make a reaction more difficult to treat.
While the extract itself does not cause sedation, a systemic reaction or the administration of emergency antihistamines can cause drowsiness. Patients should ensure they feel completely well before driving after their 30-minute observation period.
Alcohol consumption should be avoided for several hours before and after an injection. Alcohol can increase peripheral vasodilation, which may potentially accelerate the absorption of the allergen or exacerbate a systemic reaction.
Immunotherapy is typically continued for 3 to 5 years. Stopping abruptly does not cause a withdrawal syndrome, but the allergic symptoms may eventually return if the immune system has not been sufficiently desensitized.
> Important: Discuss all your medical conditions with your healthcare provider before starting Xanthium Strumarium Var. Canadense Pollen.
There are no direct food interactions with Xanthium Strumarium Var. Canadense Pollen. However, patients with "Oral Allergy Syndrome" may experience cross-reactivity between Cocklebur pollen and certain foods like melons, cucumbers, or bananas. Consuming these foods around the time of an injection might increase the overall "allergic load."
There is limited data on herbal interactions, but supplements that have immune-modulating effects (such as Echinacea or Astragalus) should be used with caution, as they could theoretically interfere with the desensitization process. Always inform your allergist of any supplements you are taking.
Xanthium Strumarium Var. Canadense Pollen will affect the results of Allergy Skin Tests and In Vitro IgE Tests (e.g., RAST or ImmunoCAP). Successful immunotherapy typically leads to an initial rise in specific IgE followed by a long-term decline, and an increase in specific IgG4 levels.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.
Xanthium Strumarium (Cocklebur) is closely related to other members of the Asteraceae family. Patients allergic to Cocklebur often show cross-sensitivity to:
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Xanthium Strumarium Var. Canadense Pollen.
Xanthium Strumarium Var. Canadense Pollen is classified as Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. The primary risk is not the extract itself, but the potential for maternal anaphylaxis, which can lead to uterine contractions, placental abruption, or fetal distress. Guidelines generally recommend that immunotherapy should not be started during pregnancy, but maintenance doses may be continued if the risk-benefit ratio is favorable.
It is not known whether the components of the allergenic extract are excreted in human milk. However, because these are large proteins that are processed locally by the immune system, it is highly unlikely that they would reach the breast milk in any significant quantity. Immunotherapy is generally considered safe for breastfeeding mothers.
Immunotherapy is effective in children and has been shown to prevent the development of asthma in children with allergic rhinitis. Most allergists wait until a child is at least 5 years old to ensure they can communicate symptoms of a systemic reaction and tolerate the injections. Use in children under 5 requires specialized pediatric allergy expertise.
Clinical studies of allergenic extracts did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. The main concern in the elderly is the presence of comorbid conditions (like heart disease) that would make an allergic reaction more dangerous. Dosing should be approached conservatively.
There are no specific guidelines for renal impairment. Since the extract's proteins are degraded into amino acids by cellular proteases, renal function does not significantly impact the clearance or safety of the product.
No dosage adjustments are required for patients with liver disease. The metabolism of allergenic proteins is an intracellular process within the immune system and does not rely on hepatic CYP450 enzymes.
> Important: Special populations require individualized medical assessment.
Xanthium Strumarium Var. Canadense Pollen acts as an immunomodulator. In diagnostic use, it triggers a Type I hypersensitivity reaction via IgE-mediated mast cell degranulation. In therapeutic use, it induces "immune tolerance." This involves the expansion of regulatory T-cells (Tregs) that produce suppressive cytokines like IL-10. These cytokines inhibit Th2 cells, which are responsible for the allergic cascade, and stimulate B-cells to produce IgG4 instead of IgE. IgG4 acts as a "blocking antibody," preventing the allergen from reaching the IgE on mast cells.
The onset of the diagnostic effect (skin test) is rapid, occurring within 15-20 minutes. The therapeutic effect is slow, often taking 6 to 12 months of consistent build-up and maintenance therapy before a significant reduction in clinical symptoms is observed. The duration of the effect can last for several years after the completion of a 3-to-5-year course of treatment.
| Parameter | Value |
|---|---|
| Bioavailability | N/A (Subcutaneous/Local) |
| Protein Binding | N/A |
| Half-life | Varies (Proteins degraded in hours/days) |
| Tmax | 15-30 minutes (for local reaction) |
| Metabolism | Proteolytic degradation by macrophages/dendritic cells |
| Excretion | Not traditionally measured |
This agent belongs to the class of Allergenic Extracts. It is specifically a non-standardized plant-derived pollen extract. Related medications include other weed extracts like Ragweed (Ambrosia) and Sagebrush (Artemisia).
Common questions about Xanthium Strumarium Var. Canadense Pollen
Xanthium Strumarium Var. Canadense Pollen is primarily used for the diagnosis and treatment of seasonal allergies caused by Cocklebur plants. In the diagnostic phase, it is applied during skin prick tests to identify if a patient is sensitive to this specific pollen. For treatment, it is used in allergen immunotherapy, commonly known as allergy shots, to desensitize the immune system over time. This process helps reduce symptoms like sneezing, itchy eyes, and nasal congestion. It is specifically indicated for patients who do not find sufficient relief from standard allergy medications or environmental avoidance.
The most common side effects are localized to the site of the injection. These include redness, swelling, itching, and a small raised bump known as a wheal. These reactions usually appear within minutes of the injection and resolve within a few hours to a day. Some patients may also experience a 'late-phase' reaction where swelling increases several hours later. While these local reactions are common, they are generally not dangerous. However, any reaction that involves the whole body, such as hives or difficulty breathing, is a medical emergency.
It is generally advised to avoid alcohol consumption on the days you receive an allergy injection. Alcohol can cause your blood vessels to dilate, which might increase the speed at which the pollen extract is absorbed into your system, potentially increasing the risk of a systemic allergic reaction. Furthermore, alcohol can sometimes worsen the symptoms of an allergic reaction or make it more difficult for you to notice early warning signs of anaphylaxis. Always check with your allergist for their specific policy regarding alcohol and your treatment schedule.
The use of allergenic extracts during pregnancy is handled with significant caution. Most medical guidelines recommend that you should not start a new course of immunotherapy while pregnant because of the risk of a severe allergic reaction (anaphylaxis), which could be harmful to the fetus. However, if you are already on a maintenance dose and have been tolerating the injections well, your doctor may decide it is safe to continue the treatment. The dose is typically not increased during pregnancy to minimize risks. Always inform your allergist immediately if you become pregnant.
Allergen immunotherapy is a long-term treatment process rather than an immediate fix. Most patients begin to notice a reduction in their allergy symptoms during the first year of treatment, often after they have reached their 'maintenance dose.' However, the full benefits are typically seen after the second or third year of consistent injections. To achieve long-lasting immunity that persists even after the injections are stopped, a full course of 3 to 5 years is usually recommended by specialists. Patience and consistency are key to the success of this therapy.
Yes, you can stop the injections at any time without experiencing physical withdrawal symptoms, as this is not an addictive medication. However, stopping the treatment before the recommended 3-to-5-year period may result in your allergy symptoms returning over time. If you stop during the 'build-up' phase, you will likely not have gained any significant long-term benefit. If you need to pause treatment due to illness or travel, your doctor will provide a schedule to safely restart, which may involve a temporary dose reduction.
If you miss a scheduled allergy shot, you should contact your allergist's office as soon as possible to reschedule. Do not attempt to 'double up' on your next dose. Depending on how long it has been since your last injection, your doctor may need to repeat your last dose or even reduce the dose slightly to ensure your safety. This is because your body's tolerance to the allergen can decrease if there is too long of a gap between exposures. Consistency is vital for both the safety and the effectiveness of the treatment.
There is no clinical evidence to suggest that Xanthium Strumarium Var. Canadense Pollen extracts cause weight gain. Unlike oral corticosteroids (such as prednisone), which can cause weight changes when used long-term, allergenic extracts are proteins that work locally on the immune system and do not affect your metabolism or appetite. If you notice weight changes while on immunotherapy, it is likely due to other factors or medications, and you should discuss this with your primary care physician.
Most standard medications, such as blood pressure pills (except beta-blockers), cholesterol medications, and even other allergy drugs like nasal sprays, can be taken safely. However, beta-blockers are a major concern because they can prevent epinephrine from working if you have a severe reaction. You should also tell your doctor if you are taking MAO inhibitors or tricyclic antidepressants. Always provide your allergist with a complete and updated list of all medications, including over-the-counter supplements, to prevent dangerous interactions.
The concept of 'generic' vs. 'brand name' is slightly different for allergenic extracts. These are biological products, and different manufacturers (such as Greer, HollisterStier, or ALK) produce their own versions of Cocklebur pollen extract. While they are not 'generics' in the way a pill is, they are essentially equivalent in clinical use. However, because these are non-standardized extracts, your doctor will usually prefer to keep you on the extract from the same manufacturer throughout your treatment to ensure the most consistent potency and safety.